Abstract
The in vitro effects of aztreonam on platelet aggregation were compared with those of cefotaxime, moxalactam, piperacillin, and carbenicillin. In addition, the in vivo effects of intravenously administered aztreonam on blood coagulation and platelet function were examined in 10 normal male volunteers in a randomized crossover study. In vitro, at concentrations of greater than 6.25 mM (2.7 mg/ml), aztreonam inhibited ADP-induced platelet aggregation in a dose-dependent manner. The effect was less than that produced by equimolar concentrations of cefotaxime, moxalactam, piperacillin, or carbenicillin. At all concentrations tested, aztreonam and cefotaxime inhibited epinephrine-induced aggregation least. All antibiotics inhibited collagen-induced aggregation, but only at inordinately high concentrations (25 mM). In vivo studies in 10 male subjects, randomly infused intravenously with 2 g of aztreonam or saline placebo every 6 h for 21 consecutive doses in a single-blind crossover study, revealed no evidence of bleeding or visible adverse side effects. Although plasma coagulation and platelet adhesion remained within normal limits in all subjects throughout the study, inhibition of ADP-induced platelet aggregation significantly (P ...Continue Reading
References
Nov 13, 1976·Lancet·K AndrassyH Storch
Jan 9, 1975·The New England Journal of Medicine·K AndrassyE Weisschedel
May 11, 1975·Antimicrobial Agents and Chemotherapy·C H BrownT W Williams
Jan 11, 1976·Antimicrobial Agents and Chemotherapy·E A NatelsonT W Williams
Dec 19, 1970·Lancet·P D McClureD Crozier
Aug 8, 1974·The New England Journal of Medicine·C H BrownC P Alfrey
Jan 7, 1983·JAMA : the Journal of the American Medical Association·M R Weitekamp, R C Aber
Jan 1, 1983·The Journal of Infectious Diseases·A P Panwalker, J Rosenfeld
Nov 1, 1982·Reviews of Infectious Diseases·N U BangL E Mattler
Feb 1, 1980·The Journal of Clinical Investigation·S J ShattilJ Turnbull
Apr 1, 1981·Antimicrobial Agents and Chemotherapy·L O GentryE A Natelson
May 1, 1983·The Journal of Antimicrobial Chemotherapy·P SomaniK Kapila
May 1, 1983·The Journal of Antimicrobial Chemotherapy·E A CopelanR J Fass
Feb 1, 1984·Antimicrobial Agents and Chemotherapy·J O BallardF R Sattler
Jan 1, 1983·Antimicrobial Agents and Chemotherapy·D P AlexanderG Rothstein
Mar 1, 1982·Reviews of Infectious Diseases·J D NelsonS Shelton
Dec 1, 1981·The Journal of Antimicrobial Chemotherapy·E A SwabbA A Sugerman
Mar 1, 1981·Archives of Internal Medicine·G D QureshiM B Slate
Apr 1, 1957·Acta Haematologica·A CLAUSS
Aug 1, 1963·The Journal of Physiology·G V BORN, M J CROSS
Citations
Jan 1, 1993·International Journal of Antimicrobial Agents·M J Hicks, C M Flaitz
Feb 25, 1988·The New England Journal of Medicine·G R Donowitz, G L Mandell
Oct 1, 1989·The British Journal of Psychiatry : the Journal of Mental Science·A J WoodD G Grahame-Smith
Oct 1, 1989·The British Journal of Psychiatry : the Journal of Mental Science·A J WoodD G Grahame-Smith
Jun 1, 1991·DICP : the Annals of Pharmacotherapy·M M Dallal, J S Czachor
Jun 20, 2020·Internal and Emergency Medicine·Eleonora CamilleriDaniela Poli